Authors: Sibin Nambidi, Sneha Pallatt, Antara Banerjee, Surajit Pathak and Prof. Dr. Mike K.S. Chan
Publisher: Molecular Biology Reports; 52(507), 2025
Publisher's URL: https://doi.org/10.1007/s11033-025-10575-3
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
💡 What’s Inside?
While traditionally known for energy production, mitochondria are now recognized as master regulators of wellness—influencing everything from neurodegeneration and immune health to metabolic balance and aging.
This article explores how Mitochondrial Organelle (MO) Therapy, using peptide formulations like MF-Plus, is revolutionizing regenerative medicine by restoring mitochondrial function and reversing cellular decline.
📌 Key Highlights:
✔️ Mitochondria regulate ATP production, calcium homeostasis, redox signaling, and apoptosis prevention
✔️ MO peptides and mitochondrial-derived vesicles (MDVs) support regeneration, anti-aging, and disease recovery
✔️ Evidence of efficacy in neurodegenerative, cardiovascular, metabolic, and dermatological conditions
✔️ Routes of administration include intramuscular, intravenous, and mesotherapy, shown to support both aesthetic and clinical benefits
✔️ Potential applications in stroke recovery, ischemia, fatty liver disease, and cellular rejuvenation
🔬 This article sheds light on mitochondria’s central role in orchestrating biological repair and how mitochondrial transfer and MO-based therapies may soon become the cornerstone of precision regenerative medicine.
Beyond the Powerhouse: Mitochondrial Organelles as Master Regulators of Wellness
by
Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Dr. Yuriy Nalapko, Krista Casazza, Dr. Dmytro Klokol and Jonathan R.T. Lakey
American Journal of Biomedical Science & Research; 27(3), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003552.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
💡 What’s Inside?
This cutting-edge review explores two next-generation peptide platforms: Nano-Organo Peptides (NOPs) and Mitochondria-Targeted Peptides (MTPs) as precision therapies for Acute Kidney Injury (AKI) and Chronic Kidney Disease (CKD).
📌 Key Highlights:
✔️ Nano-Organo Peptides (NOPs): Deliver peptides to subcellular compartments (e.g., mitochondria, lysosomes, ER) for targeted renal repair
✔️ Mitochondria-Targeted Peptides (MTPs): Protect kidney mitochondria by stabilizing cardiolipin, reducing oxidative stress, and restoring bioenergetics
✔️ Promising results in fibrosis attenuation, immune modulation, glomerular protection, and tubular cell survival
✔️ Therapeutic examples like SS-31 (elamipretide) show effectiveness in ischemia-reperfusion injury, diabetic nephropathy, and age-related renal decline
✔️ Highlights early clinical studies, renal-targeted delivery strategies, and emerging precision nephrology applications
This review outlines the scientific rationale, delivery systems, mechanistic targets, and clinical potential of peptide-based therapeutics in nephrology, opening new pathways for overcoming the limitations of conventional kidney treatments.
Emerging Peptide Therapies for Kidney Disease: Focus on Nano-Organo and Mitochondria-Targeted Strategies
by
Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Krista Casazza and Jonathan R.T. Lakey
American Journal of Biomedical Science & Research; 27(3), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003551.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
💡 About the Article:
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition with no FDA-approved treatments targeting its core biological mechanisms. This review explores the promising role of therapeutic peptides in modulating the underlying neurobiology of ASD.
📌 Key Highlights:
✔️ Peptides can cross the blood-brain barrier and target neuroinflammation, synaptic plasticity, and mitochondrial dysfunction
✔️ Mitochondria-derived peptides (MDPs) like Humanin, MOTS-c, and SHLP2 enhance neuronal survival, reduce oxidative stress, and modulate immune responses
✔️ Nano Organo Peptides (NOPs) and Mitochondrial Organelle (MO) Peptides represent next-gen therapies for metabolic restoration, neuroimmune modulation, and synaptic repair
✔️ Clinical studies on peptides like Oxytocin, VIP, Melatonin show early promise in improving social behaviors, sleep, and reducing neuroinflammation in ASD
✔️ Peptide therapies may bridge neurobiology with precision therapeutics, offering a path toward true disease-modifying interventions for ASD
Peptide Neuromodulation in Autism Spectrum Disorder: Targeting Neuroinflammation, Mitochondrial Dysfunction, and Synaptic Plasticity
by
Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Krista Casazza, Ian Jenkins and Jonathan R.T. Lakey
American Journal of Biomedical Science & Research; 27(2), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003532.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
💡 About the Publication:
This powerful review explores how mesenchymal stem cells (MSCs) and neural stem/progenitor cells (NSPCs) offer transformative potential in the treatment of complex neurodegenerative and neuroinflammatory diseases such as Alzheimer’s, Parkinson’s, ALS, MS, stroke, TBI, and SCI.
These two stem cell types are uniquely positioned to:
✔️ Address key pathologies like neuronal loss, inflammation, and blood-brain barrier (BBB) dysfunction
✔️ Promote cell replacement, neuroprotection, synaptic plasticity, and remyelination
✔️ Deliver therapeutic effects through direct regeneration and powerful paracrine signaling
✔️ Reduce oxidative stress and neuroinflammation, while enhancing recovery through trophic and immunomodulatory actions
With insights from clinical and preclinical models, the article also compares the unique advantages and limitations of MSCs and NSPCs and provides a roadmap for optimizing their clinical translation
Restoring the Degenerating Brain: Mesenchymal and Neural Stem Cells in Neurotherapeutics
by
Carolina Bluguermann, Ian Jenkins, Krista Casazza, Waldemar Lernhardt, Bradley Robinson, Pedro Gutierrez-Castrellon, Ivan Garcia Vitolas, Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Xia Ling, Yizhen Deng, Hongjin Wu, Jonathan R.T. Lakey and Adrian Mutto
Neurology – Research & Surgery; 8(1), 2025
https://www.scivisionpub.com/abstract-display.php?id=3846
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
A cutting-edge review in the American Journal of Biomedical Science & Research explores a question that could reshape the future for millions of children: Can stem cell therapy reverse the course of Type 1 Diabetes in the pediatric population?
Authored by an international team including European Wellness founder Prof. Dato’ Sri Dr. Mike Chan and Prof. Dato’ Sri Dr. Michelle Wong, this pivotal paper examines how mesenchymal, hematopoietic, and pluripotent stem cells might not only shield β-cells from autoimmune attacks but also regenerate insulin-producing function. 🧬
Key Highlights:
✅ Immune Resetting with HSCs shows potential in stopping early-stage autoimmune destruction.
✅ MSC Therapies demonstrate glycemic control benefits with immunomodulation.
✅ iPSCs & ESCs pave the way for personalized β-cell regeneration.
✅ Pediatric Trials reveal encouraging early safety and efficacy signals.
The findings suggest stem cells could one day offer more than just ‘disease management’ for children around the world who suffer from this disease…
Diabetes in the Pediatric Population-can Stem Cell Therapy Overcome the Associated Burden Disease
by
Jonathan R.T. Lakey, Carolina Bluguermann, Ian Jenkins, Krista Casazza, Waldemar Lernhardt, Eric J. Mathur, Bradley Robinson, Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Xia Ling, Yizhen Deng, Hongjin Wu, Adrian Mutto and Pedro Gutierrez-Castrellon
American Journal of Biomedical Science & Research; 26(6), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003519.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Authors: Prof. Dr. Mike K.S. Chan and Prof. Dr. Michelle B.F. Wong
Published by: EUROPEAN WELLNESS ACADEMY
Unlock the future of healing with Compendium of Diseases and Disorders: Clinical Applications of Stem Cells with Precision in Regenerative Medicine. Authored by pioneering scientist Prof. Dr. Mike Chan, this groundbreaking volume bridges cutting-edge research and real-world clinical application. It explores how targeted progenitor and precursor stem cells can transform the treatment of a wide range of diseases—from neurodegenerative conditions and cardiovascular disorders to aging-related syndromes and immune deficiencies. Designed for healthcare professionals, researchers, and innovators, this compendium offers a visionary yet practical guide to the evolving frontiers of regenerative medicine, emphasizing precision, ethical responsibility, and hope for conditions once deemed untreatable.
Prof. Dr. Mike K.S. Chan is an author, educator, and pioneer in Cellular, Organo, and Cell Membrane Therapies in Europe and Asia since the early 1980s. He founded one of the world’s largest research groups in Bio-Molecular Medicine, headquartered in Switzerland and Germany, with a global presence in nearly eighty countries. He has delivered more than 1,000 lectures, seminars, and symposiums worldwide in the fields of anti-aging, cell regeneration, bio-regenerative medicine, and stem cell therapies.
He is the author or co-author of over 50 scientific and medical books covering stem cells, aging, neurodegenerative and neurodevelopmental disorders, metabolic diseases, and biological as well as regenerative medicine. Prof. Dr. Chan serves on the board and chairs the Scientific Committee for Regenerative Medicine at ESAAM. He is also an Associate Professor at AASCP, USA; an Adjunct Professor and Fellow of Lincoln University College, USA (Kuala Lumpur campus); Chairman of the Medical Association for Regenerative Medicine in Japan (MMJ – Multi-Dimensional Holistic Medical Team Japan); and a Senator of BWA, Germany (Federal Association for Economic Development and Foreign Trade), representing China, Indonesia, and Malaysia.
He has played a pivotal role in advancing medical and wellness tourism, as well as educational tourism, in Switzerland, Germany, and Malaysia collaborating with physicians from the USA, Portugal, Poland, Belgium, China, Spain, the UK, Indonesia, Taiwan, Australia, New Zealand, Thailand, Singapore, Vietnam, the Philippines, and the Middle East.
Prof. Dr. Michelle B.F. Wong is a distinguished scientist, researcher, and educator, actively engaged in stem cell research and development (R&D), with a particular focus on fetal precursor stem cell therapy. For over three decades, she has served as Co-Founder, Senior Technical Advisor, and Researcher at FCTI Inc., a company specializing in stem cell research and bio-regenerative medicine.Her solid academic foundation in nutrition and naturopathy has facilitated a seamless transition into R&D within the field of stem cell bioregenerative medicine.
Dr. Wong is also a highly respected speaker, regularly delivering presentations at educational programs and international conferences on topics such as stem cells, cell therapy, and biological medicine—benefiting physicians and healthcare practitioners worldwide.
Authors: Krista Casazza, Carolina Bluguermann, Ian Jenkins, Bradley Robinson, Pedro Gutierrez-Castrellon, Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Yizhen Deng, Hongjin Wu, Adrian Mutto and Jonathan R.T. Lakey
Publisher: American Journal of Biomedical Science & Research; 26(5), 2025
Publisher's URL: https://biomedgrid.com/pdf/AJBSR.MS.ID.003474.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
💡 About the Publication:
This comprehensive review explores the cutting-edge advancements in stroke and brain injury management, focusing on the revolutionary integration of cellular, molecular, and regenerative therapies.
📌 Key Highlights:
✔️ Explores the complex biological mechanisms of neurodegeneration and repair
✔️ Showcases the role of stem cells, peptides, and mitochondrial therapies in promoting neuroregeneration
✔️ Highlights the latest developments in personalized medicine, neurorehabilitation, and neuroprotective strategies
✔️ Bridges neuroscience, regenerative medicine, and functional recovery—offering renewed hope for patients with neurological injuries
This publication represents the next generation of neurorepair science, merging evidence-based research with futuristic approaches to restore brain function and enhance patient quality of life.
Next Gen in Neurorepair: Peptide Therapeutics for the Injured and Aging Brain
by
Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Krista Casazza, Ian Jenkins and Jonathan R.T. Lakey
American Journal of Biomedical Science & Research; 26(6), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003509.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Authors: Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Krista Casazza, Ian Jenkins and Jonathan R.T. Lakey
Publisher: American Journal of Biomedical Science & Research; 26(6), 2025
Publisher's URL: https://biomedgrid.com/pdf/AJBSR.MS.ID.003494.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Authors: Prof. Dr. Mike K.S. Chan, Siti Azmah Jambo, Mohd. Iskandar Jumat, Florisa Landa, Nur Shafawati Saili, Dianah Florentius, Nuryasmin Ezzaty, Raz Haziqah Hani Razali, Brenda Song Pei Chui, Aziera Farhanah Adihidayah Suardi, Sze Huey Sang, Dr. Dmytro Klokol, Dr. Olha Nishkumai, Dr. Margarita Iemeliyanova, Dr. Yuriy Nalapko, Thomas Skutella, Jonathan R.T. Lakey and Prof. Dr. Michelle B.F. Wong
Publisher: Journal of Stem Cell Research; 6(1), 2025
Publisher's URL: https://doi.org/10.52793/JSCR.2025.6(1)-71
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Authors: Prof. Dr. Mike K.S. Chan and Dr. Dina Tulina
Published by: EUROPEAN WELLNESS ACADEMY
Medical Research: ISBN: 9781662963216, eISBN: 9781662963353
Stroke is a critical medical emergency and a leading cause of disability and death worldwide. Within minutes of the stroke or interruption of the blood supply, the affected cells begin to die, potentially leading to devastating neurological consequences. This book explores the science behind stroke, its causes, mechanisms, and management, discussing the biological processes that govern cerebral circulation and mechanisms for repair and recovery potential.
The book provides an in-depth look at the biological approach to stroke management, including cellular and molecular mechanisms to understand stroke pathophysiology, from energy failure and excitotoxicity to immune responses and neurodegeneration. The manuscript comprehensively discusses the role of neuropeptides, growth factors, and other biologically active molecules that may aid in brain repair and functional recovery. It also highlights the physiotherapeutic and regenerative strategies, emphasising the importance of neurorehabilitation techniques, including physiotherapy, brain stimulation, and emerging regenerative medicine approaches to enhance recovery. Next, a post-stroke recovery and rehabilitation chapter examines strategies to maximise neurological function, including dietary interventions, physical activity, cognitive therapy, and assistive technologies.
Beyond traditional treatment, the book presents how cutting-edge therapies, including stem cell research, neuroplasticity training, and personalised medicine, transform post-stroke care. With advances in neuroscience and regenerative medicine, there is renewed hope for stroke survivors to regain lost function and improve their quality of life. This book offers an insightful and scientifically-backed resource on the biological mechanisms of stroke and the latest advancements in management and rehabilitation.
Professor Dato’ Sri Dr. Mike K.S. Chan is a pioneer of Cellular and Cell Membrane Therapy in Europe and Asia since the early 1980’s. He founded one of the world’s largest researchers of Bio-Molecular Medicine based in Switzerland and Germany with a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of antiaging, cell regeneration, regenerative medicine, and stem-cell therapies.
Dr Dina Tulina is a specialist in anti-aging and regenerative medicine with extensive experience in the field. Basing her knowledge on scientific and research experience within the scope of neuropsychiatry (age-related brain changes and associated cognitive and mental disorders), Dr Dina has expanded and enriched her expertise by incorporating preventative medicine, natural and complementary therapies for age-related changes, and the use of biologics in regenerative medicine. Guided by the philosophy "He, who owns the youth, owns the future", Dr Dina is deeply passionate about the educational aspects of anti-aging medicine and wellness.
With over 830 million people affected globally, metabolic syndrome and type 2 diabetes are among the fastest-growing chronic conditions of our time. This study introduces a groundbreaking, non-pharmacological prevention strategy using low-intensity neuromuscular and musculoskeletal activation exercises—tailored especially for individuals with mobility limitations.
📌 Key Findings:
✔️ Up to 20.4% reduction in post-meal blood glucose levels
✔️ Significant decrease in systolic and diastolic blood pressure
✔️ Effective activation of GLUT4 and AMPK pathways—even without insulin
✔️ Positive outcomes achieved in just 12 minutes of seated exercise
✔️ Supports cardiovascular health, metabolic balance, and anti-aging benefits
These results highlight how structured, accessible exercise routines can be a vital part of bioregenerative medicine, improving glycemic control and promoting healthy aging—especially in populations with limited access to conventional therapies.
Metabolic Syndrome Prevention Protocol: Musculoskeletal and Peripheral Nervous System Modalities
by
Prof. Dr. Mike K.S. Chan, Stephanie Ann Sardar, Mohd Shahril Abdul Rahim, Prof. Dr. Michelle B.F. Wong, Dr. Yuriy Nalapko, Dr. Simon Yefimov, Thomas Skutella and Jonathan R.T. Lakey
Journal of Neurological Sciences and Research; 5(1), 2025
http://doi.org/10.52793/JNSR.2025.5(1)-44
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Authors: Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Stephanie Ann Sardar, Mohd Shahril Abdul Rahim, Dr. Yuriy Nalapko, Dr. Simon Yefimov, Thomas Skutella and Jonathan R.T. Lakey
Publisher: American Journal of Biomedical Science & Research; 26(4), 2025
Publisher's URL: https://biomedgrid.com/pdf/AJBSR.MS.ID.003461.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
In a groundbreaking study, researchers are now exploring the potential of using a patient’s own bone marrow-derived stem cells to provide stem cell therapy for managing diabetes – essentially harnessing the body’s own power! 💪
Here are some key insights…
✅ A Safer Approach: Could using a patient’s own bone marrow stem cells (autologous BMMNCs) offer a potentially safer route for diabetes therapy by minimizing risks seen with donor cells?
✅Potential for Better Control: Clinical studies suggest autologous BMMNC infusion holds promise for improving blood sugar levels (HbA1c) and possibly reducing insulin needs in Type 1 & Type 2 Diabetes.
✅ Hope for Patients with Complications: This therapy shows potential for addressing difficult diabetes-related issues e.g. conditions like kidney problems (nephropathy) or non-healing foot ulcers.
Clinical Safety And Therapeutic Efficacy Of Autologous Bone-Marrow Derived Stem Cells In Restoring Glycemic Control And Treating Complications In Diabetic Patients
by
Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Yanmin Wang, Michael Alexander, Alejandro Mesples, Ian Jenkins and Jonathan R.T. Lakey
American Journal of Medical and Clinical Research & Reviews; 3(4), 2024
https://doi.org/10.58372/2835-6276.1162
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Diabetes remains a global health challenge, often requiring lifelong management. But what if we could go beyond managing symptoms and explore pathways to functional treatment?
Some key insights…
✅ Pluripotent Stem Cells (hPSCs/iPSCs): These remarkable cells hold the potential to be transformed into insulin-producing beta cells, offering a path towards replacing lost function and potentially achieving insulin independence. Early trials are showing encouraging results!
✅ Mesenchymal Stem Cells (MSCs): Allogeneic MSCs show promise in protecting existing beta cells and modulating the immune system, potentially slowing disease progression and improving transplant outcomes.
✅ Overcoming Hurdles: While challenges like immune rejection and costs exist, researchers are actively developing strategies like immune evasion techniques and bioengineered scaffolds to enhance the safety and effectiveness of these therapies.
Stem Cells: Novel Opportunities for Patients with Diabetes
by
Prof. Dr. Mike K.S. Chan, Jonathan R.T. Lakey, Carolina Bluguermann, Krista Casazza, Adrian Mutto, Bradley Robinson, Zijiang Yang, Ivan Lopez Vitolas, Ian Jenkins, Waldemar Lernhardt and Pedro Gutiérrez Castrellón
American Journal of Biomedical Science & Research; 26(4), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003454.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
🔍 What’s Inside?
Known predominantly for its role in kidney health and anti-aging, the Klotho protein is now gaining recognition for its powerful influence on cardiovascular function.
This review explores:
✔️ The systemic role of Klotho beyond renal function
✔️ How Klotho deficiency contributes to hypertension, arterial stiffness, cardiac hypertrophy, and vascular calcification
✔️ The emerging therapeutic potential of Klotho in cardioprotection, vascular aging, and endothelial function
✔️ Links between Klotho signaling pathways and oxidative stress, inflammation, and calcium-phosphate balance
By moving beyond the kidney, this paper reframes our understanding of Klotho as a critical cardiovascular regulator—highlighting its promise in the fight against heart disease and age-related vascular decline.
Beyond the Kidney-Klotho and the Cardiovascular System
by
Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Dr. Yuriy Nalapko, Krista Casazza, Dr. Dmytro Klokol, Dr. Olha Nishkumai, Ian Jenkins and Jonathan R.T. Lakey
American Journal of Biomedical Science & Research; 25(6), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003387.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
💡 What’s it about?
This insightful review explores the Klotho protein, often dubbed the “anti-aging gene”, and its intricate relationship with obesity and chronic inflammation—two of the most critical health issues facing modern society.
The article dives into:
✔️ How Klotho acts as a metabolic guardian, regulating insulin sensitivity and energy balance
✔️ The vicious cycle between obesity and systemic inflammation
✔️ How low Klotho expression may accelerate metabolic dysfunction and age-related diseases
✔️ The potential for targeting the Klotho pathway in developing new therapeutic approaches for obesity, diabetes, and chronic inflammatory conditions
By understanding this molecular triad, researchers and clinicians can uncover promising directions for regenerative medicine, longevity science, and metabolic health interventions.
Klotho, Obesity, and Inflammation: A Triad of Metabolic Regulation
by
Prof. Dr. Mike K.S. Chan, Prof. Dr. Michelle B.F. Wong, Dr. Yuriy Nalapko, Krista Casazza, Dr. Dmytro Klokol, Dr. Olha Nishkumai, Ian Jenkins and Jonathan R.T. Lakey
American Journal of Biomedical Science & Research; 25(6), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003376.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Did you know that the human brain is a complex network of billions of diverse cells? Understanding each type of cell and their function could be the key to unlocking the secrets behind brain health, aging, and neurological disorders…
Some crucial insights include:
✅ Glial cells are just as numerous and vital as neurons! They provide essential support, maintaining the brain’s environment and ensuring rapid communication.
✅ Mapping brain cells in detail is critical for developing targeted treatments for neurodegenerative diseases like Alzheimer’s and Parkinson’s.
✅ Age-related changes don’t affect the whole brain equally; areas crucial for decision-making (like the prefrontal cortex) tend to be the most severely affected.
Exploring the Complexity of the Human Brain: Cell Types, Numbers, and Lobar Functions
by
Prof. Dr. Mike K.S. Chan, Mohd Iskandar Jumat, Florisa Landa, Nur Shafawati Saili, Siti Azmah Jambo, Dianah Florentius, Nuryasmin Ezzaty, Raz Haziqah Hani Razali, Brenda Son Pei Chui, Aziera Farhanah Adihidayah Suardi, Sze Huey Sang, Prof. Dr. Michelle B.F. Wong, Thomas Skutella and Jonathan R.T. Lakey
American Journal of Biomedical Science & Research; 26(4), 2025
https://biomedgrid.com/pdf/AJBSR.MS.ID.003452.pdf
MORE PUBLICATIONS:
https://european-wellness.eu/publications/
Authors: Prof. Dr. Mike K.S. Chan and Dr. Alaa Abdelkairm Fouad
Publisher: Journal of Biology and Medical Research; 6(1), 2025
Publisher's URL: https://www.imedpub.com/articles/advancing-cellular-therapy-with-the-ace-pico-protocol-overcoming-multidosing-challenges-in-stem-cell-applications.php?aid=53481
MORE PUBLICATIONS:
https://european-wellness.eu/publications/